(Q39780234)

14 September 2017

1 reference

title

Effects of renal disease upon drug disposition (English)

1 reference

14 September 2017

Effects of Renal Disease upon Drug Disposition (English)

1 reference

https://api.crossref.org/works/10.3109/03602537808993789

8 April 2023

1 reference

Reidenberg MM

1

1 reference

14 September 2017

Drayer DE

2

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 January 1978

1 reference

full work available at URL

14 September 2017

http://www.tandfonline.com/doi/pdf/10.3109/03602537808993789

1 reference

https://api.crossref.org/works/10.3109/03602537808993789

8 April 2023

published in

Drug Metabolism Reviews

1 reference

14 September 2017

volume

8

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

293-302

1 reference

Diphenylhydantoin Metabolism in Uremia

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993789

Kinetics of diphenylhydantoin in uraemic patients: consequences of decreased plasma protein binding

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993789

Salivary phenytoin concentrations in epilepsy and in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993789

The plasma half-life of antipyrine in chromic uraemic and normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993789

Pentobarbital elimination in patients with poor renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993789

Commentary: a physiological approach to hepatic drug clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993789

Oxidative drug metabolism in liver microsomes from uremic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993789

The binding of drugs to plasma proteins from patients with poor renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993789

The binding of drugs to plasma proteins and the interpretation of measurements of plasma concentrations of drugs in patients with poor renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993789

Protein binding of drugs in uremic and normal serum: the role of endogenous binding inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993789

Influence of pH on the benzodiazepine-human serum albumin complex. Circular dichroism studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993789

Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993789

Decreased drug binding by serum albumin during renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993789

Alteration of plasma albumin in relation to decreased drug binding in uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993789

Active drug metabolites and renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993789

Cumulation of N-acetylprocainamide, an active metabolite of procainamide, in patients with impaired renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993789

Accumulation of normeperidine, an active metabolite of meperidine, in patients with renal failure of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993789

Renal clearance of oxipurinol, the chief metabolite of allopurinol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993789

Unique Biosynthesis by Kidney of a Biologically Active Vitamin D Metabolite

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03602537808993789

The biotransformation of drugs in renal failure

21 January 2018

2

1 reference

https://api.crossref.org/works/10.3109/03602537808993789

Barbiturate narcosis in uraemia

8 April 2023

14

1 reference

https://api.crossref.org/works/10.3109/03602537808993789

Determination of furosemide in blood plasma and its binding to proteins in normal plasma and in plasma from patients with acute renal failure.

8 April 2023

20

1 reference

https://api.crossref.org/works/10.3109/03602537808993789

The effect of haemodialysis on the binding capacity of albumin

8 April 2023

21

1 reference

https://api.crossref.org/works/10.3109/03602537808993789

The Alteration of Plasma Proteins in Uremia as Reflected in their Ability to Bind Digitoxin and Diphenylhydantoin

8 April 2023

24

1 reference

https://api.crossref.org/works/10.3109/03602537808993789

Impairment of cognitive function associated with hydroxyamylobarbitone accumulation in patients with renal insufficiency

8 April 2023

33

1 reference

https://api.crossref.org/works/10.3109/03602537808993789

8 April 2023

Identifiers

1 reference

14 September 2017

1 reference